KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $36,000 | -78.4% | 120,841 | 0.0% | 0.00% | -71.4% |
| Q1 2022 | $167,000 | -43.0% | 120,841 | -50.0% | 0.01% | -41.7% |
| Q4 2021 | $293,000 | -52.7% | 241,857 | +2.2% | 0.02% | -56.4% |
| Q3 2021 | $620,000 | -50.5% | 236,757 | +0.2% | 0.06% | -52.2% |
| Q2 2021 | $1,252,000 | -7.1% | 236,257 | +18.2% | 0.12% | -12.9% |
| Q1 2021 | $1,348,000 | +17.3% | 199,954 | +18.0% | 0.13% | +8.2% |
| Q4 2020 | $1,149,000 | +54.2% | 169,429 | +70.6% | 0.12% | +32.6% |
| Q3 2020 | $745,000 | – | 99,288 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |